Bruker Corp. Appoints Bonnie H. Anderson to Board of Directors

Facebook X LinkedIn Email
BILLERICA, Mass., Sept. 10, 2020 — Bruker Corp. has appointed Bonnie H. Anderson to its board of directors. Anderson is co-founder, chairman of the board, and CEO of Veracyte, a global genomic diagnostics company. Anderson spent 18 years at Beckman Coulter in leadership positions across the global life sciences and diagnostic business segments, including flow cytometry, before co-founding Veracyte. The company now qualifies as public global, with a market capitalization of nearly $2 billion.

"The addition of Bonnie to our board is very timely as we continue to evolve our Project Accelerate initiatives in multiomics life science and clinical research tools toward molecular diagnostics solutions,” said Frank Laukien, Bruker’s chairman, president, and CEO.

The appointment was effective as of Sept. 3.

Bonnie H. Anderson

Published: September 2020
flow cytometry
A method of measuring the characteristics of microscopic particles, usually cells, as they flow in a fluid stream through a beam of light. Particles may be stained with fluorescent dye and the fluorescence detected via laser illumination.
BrukerAmericasappointmentslife sciencespeopleboard of directorsboard of directors appointmentmedical diagnosticsbiomedical diagnosticsBiophotonicsflow cytometrymolecular diagnosticsOpticsscientific instrumentsBusiness

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.